Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin and Vitamin D in Early Stage CLL/SLL
NCT02100423Phase 2Completed
- Start
- Oct 2014
- Primary completion
- Apr 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of curcumin in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL). Started Oct 2014; status: completed.
02
Drugs
curcumin
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT02100423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02100423.